Death due to liver failure during endocrine therapy for premenopausal breast cancer.
Rabaglio
Manuela
M
Ruepp
Barbara
B
D000328:Adult; D000730:Androstadienes / Q000008:administration & dosage / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D047072:Aromatase Inhibitors / Q000009:adverse effects; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D056486:Chemical and Drug Induced Liver Injury / Q000150:complications* / Q000209:etiology; D004155:Diphenhydramine / Q000008:administration & dosage / Q000009:adverse effects* / Q000633:toxicity; D004357:Drug Synergism; D020847:Estrogen Receptor Modulators / Q000009:adverse effects; D017809:Fatal Outcome; D005260:Female; D006519:Hepatitis, Alcoholic / Q000150:complications*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D017114:Liver Failure, Acute / Q000139:chemically induced*; D008875:Middle Aged; D017697:Premenopause; D012651:Self Medication; D013629:Tamoxifen / Q000008:administration & dosage / Q000009:adverse effects*; D017329:Triptorelin Pamoate / Q000008:administration & dosage / Q000009:adverse effects*
D000730:Androstadienes; D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D020847:Estrogen Receptor Modulators; D006993:Hypnotics and Sedatives; D017329:Triptorelin Pamoate; D013629:Tamoxifen; D004155:Diphenhydramine; C056516:exemestane